Good post. I tend to agree with your sentiments.
"- how exactly, well that's a different question."
This is my consideration at present too. The options have to be either cancelled or exercised as a part of any full buyout scenario. I do not believe that MT & the board would attempt to force through a deal with no consideration for options (but I have been wrong before, on occasion).
Here is the spread on what was paid to various option holders in the Resapp deal for anyone that's interested:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst, page-682
-
- There are more pages in this discussion • 743 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $89.08M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1521 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.0¢ | 1500 | 1 |
View Market Depth
| Last trade - 09.55am 19/06/2024 (20 minute delay) ? |
| PAA (ASX) Chart |
Day chart unavailable